Varian Medical price target raised to $84 from $79 at RW Baird Baird raised its price target on Varian Medical following yesterday's meetings with management. The firm believes the new reimbursement rates will drive order trends higher, that European trends remain stable, and its x-ray division is well positioned to grow double digits. Shares are Buy rated.
News For VAR From The Last 14 Days
Check below for free stories on VAR the last two weeks.